Investigating the related factors with the severity of COVID-19 in hospitalized patients: A cross-sectional study in Semnan, Iran

authors:

avatar Masoumeh Ebrahimi Tavani , avatar Farid Gharibi , avatar Mehdi Haghi , avatar Farid Gharibi , *

Koomesh: Vol.25, issue 2; 229-239
published online: August 02, 2023
article type: Research Article
received: September 01, 2022
accepted: February 02, 2023

how to cite: Ebrahimi Tavani M, Gharibi F, Haghi M, Gharibi F. Investigating the related factors with the severity of COVID-19 in hospitalized patients: A cross-sectional study in Semnan, Iran. koomesh. 2023;25(2):e152821. 

Abstract

Introduction: Identifying the factors affecting the severity of a disease can lead to the adoption of purposeful preventive and therapeutic actions, and subsequently improve health outcomes. This study aimed to investigate the related demographic and underlying factors with the severity of COVID-19 in hospitalized patients. Materials and Methods: This cross-sectional study was conducted on 400 patients with COVID-19 hospitalized at Kowsar Hospital of Semnan, Iran. The study tool was a researcher-made questionnaire whose content validity was confirmed by a committee of ten experts with content validity ratio (CVR) and content validity index (CVI) scores equal to 0.92 and 0.89, respectively. The systematic random sampling method was used in this study, and the required data were collected by reviewing medical records and conducting interviews with patients. All analyses were performed using SPSS19, and P<0.05 was considered significant. Results: The mean age of patients was 56.20 (±59.77) years, and women (53%) and men (47%) had a relatively similar share. Among the patients, 24% were hospitalized in the intensive care unit (ICU) and 7% experienced coma. Also, 99% of patients suffered from serious COVID-19 complications. The rates of pulmonary, cardiovascular, and renal complications were 96%, 68%, and 6%, respectively. There was a significant relationship between the severity of disease with such variables as age, education level, employment status, being native, place of receiving care, previous heart disease, high blood pressure, diabetes, immunodeficiency, obesity, and physical activity or a job requiring physical activity (P<0.05). Conclusion: The study results showed that a wide range of demographic factors, access to health care, health-seeking behaviors, having an underlying disease, and having a healthy lifestyle are related to the severity of COVID-19.

References

  • 1.

    Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-192.

  • 2.

    Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020; 395: 689-697.

  • 3.

    Rahman MM, Gilmour S, Saito E, Sultana P, Shibuya K. Health-related financial catastrophe, inequality and chronic illness in Bangladesh. PLoS ONE 2013; 8: e56873.

  • 4.

    Sorci G, Faivre B, Morand S. Explaining among-country variation in COVID-19 case fatality rate. Sci Rep 2020; 10: 18909.

  • 5.

    Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online 2020; 22: 1-10.

  • 6.

    Zhu J, Zhong Z, Ji P, Li H, Li B, Pang J. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Commun Health 2020; 8: e000406.

  • 7.

    Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie 2020; 179: 85-100.

  • 8.

    Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS- CoV-2 and COVID-19. Nat Rev Microbiol 2020; 6: 1-14.

  • 9.

    Coccia M. High health expenditures and low exposure of population to air pollution as critical factors that can reduce fatality rate in COVID-19 pandemic crisis: a global analysis. Environ Res 2021; 199: 1-9.

  • 10.

    Arab S, Ebrahimi Z, Izadi A, Madanchi H, Yarmohammadi M, Darban M. Relationship between the history of kidney disease, clinical findings, hosiptalization duration, and mortality in covid-19 patients. Koomesh 2022; 24: 102-108. (Persian).

  • 11.

    Shanbehzadeh M, Valinezhadi A, Afrah R, Kazemi-Arpanahi H, Orooji A, Kafashian M. Comparison of nachin-learning algorithms efficiency to build a predictive model for mortality risk in covid-19 hospitalized patients. Koomesh 2022; 24: 128-138. (Persian).##.

  • 12.

    Mutyambizi C, Pavlova M, Hongoro C, Booysen F, Groot W. Incidence, socio-economic inequalities and determinants of catastrophic health expenditure and impoverishment for diabetes care in South Africa: a study at two public hospitals in Tshwane. Int J Equity Health 2019; 18: 1-15.

  • 13.

    Yang X, Yu Y, Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single centered, retrospective, observational study. Lancet Respir Med 2020; 8: e26.

  • 14.

    Hu B, Guo H, Zhou P, Li Shi Z. Characteristics of SARS- CoV-2 and COVID-19. Nat Rev 2021; 19: 141-154.

  • 15.

    Rahman S, Singh K, Dhingra S. The double burden of the COVID-19 pandemic and polypharmacy on geriatric population - public health implications. Ther Clin Risk Manag 2020; 16: 1007-1022.

  • 16.

    Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Microbiol Rev 2021; 34: e00228-20.

  • 17.

    Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience 2020; 42: 505-514.

  • 18.

    Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. N Engl J Med 2020; 382: 1663-1665.

  • 19.

    Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91-95.

  • 20.

    Wu C, Chen X, Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020; 180: 1-11.

  • 21.

    Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062.

  • 22.

    Xu Z, Shi L, Wang Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420-422.

  • 23.

    Gasecka A, Borovac JA, Guerreiro RA. Complications in Patients with COVID-19: pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2020; 19: 1-15.

  • 24.

    Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus dis-ease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med 2020; 130: 304-309.##https://doi.org/10.20452/pamw.15272.

  • 25.

    Qian JY, Wang B, Liu BC. Acute kidney injury in the 2019 novel Coronavirus disease. Kidney Dis 2020; 6: 318-323.

  • 26.

    Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8: e21.

  • 27.

    Tham KW, Lee PC, Lim CH. Weight management in obstructive sleep apnea: medical and surgical options. Sleep Med Clin 2019; 14: 143-153.

  • 28.

    Memtsoudis SG, Ivascu NS, Pryor KO. Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea. Br J Anaesth 2020; 125: e262-e263.

  • 29.

    Vepa A, Bae JP, Ahmed F. COVID-19 and ethnicity: a novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020; 14: 1043-1051.

  • 30.

    Jin JM, Bai P, He W. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 2020; 8: 152.

  • 31.

    Grard C, Maggipinto G. Minon JMCOVID-19 and ABO blood group: another viewpoint. Br J Haematol 2020; 190: e93-e94.